TheJobsMapResponse Pharmaceuticals jobs and careers
As of October 23, 2026, Response Pharmaceuticals has no open roles listed.
About Response Pharmaceuticals
Response Pharmaceuticals is developing its lead asset, RDX-002, a first-in-class weight management and cardiometabolic health drug with confirmed efficacy and safety in >550 subjects. All programs are in Phase 2 clinical development. Our initial focus is on helping underserved patient populations taking antipsychotic medications for disabling mental illnesses to combat weight gain and metabolic dysregulation associated with these treatments. Antipsychotic-induced weight gain (AIWG) is a drug-induced epidemic within the already vulnerable population of patients with severe mental illness, and is contributing to a growing mortality gap between people with mental illness and the general population. Additionally, RDX-002 is being evaluated in other settings in which clinically significant weight gain and/or adverse metabolic changes are prevalent.
Founded in 2021 by Eric Keller and Paul Sweetnam.
- Founded
- 2021
- Employees
- 1 to 10
- Total funding
- $11.9M
Jobs at Response Pharmaceuticals
No open positions right now. Explore more companies on TheJobsMap.
Response Pharmaceuticals jobs: common questions
- Is Response Pharmaceuticals hiring right now?
- Response Pharmaceuticals has no open roles listed as of October 23, 2026. Roles appear here as soon as they are posted on Response Pharmaceuticals's careers site.
- How do I apply for a job at Response Pharmaceuticals?
- Pick a role on Response Pharmaceuticals's TheJobsMap page and select Apply. Every listing links to the original posting on Response Pharmaceuticals's own careers site, so you apply directly with the employer.